Pharma goes online: 50 apps from top Big Pharmas
The popularity of smartphones like the iPhone has created an entirely new marketplace for mobile applications.
Pharmaceutical companies are starting to see the value these apps can provide. A properly designed app-be it a medication tracker, a disease calculator, an educational catalogue, or a patient diary-can improve the lives of patients and physicians and thus increase customer collaboration.
At the same time, a well-designed app in the hands of sales reps and marketers can maximize organizational efficiency and create competitive advantage when it comes to selling drugs.
In the past year, pharma investments in smartphone apps, social media platforms, and wireless devices have grown 78 percent…
If you go to the Apple App Store today, you’ll find thousands of medical applications; about 50 of these belong to the pharmaceutical industry. Abbott, AstraZeneca, Bayer, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, and Sanofi-aventis all have apps on the market.
Many of these apps target physicians and nurses:
- Novartis’ GIST Calculator (Risk of recurrence for Gastrointestinal Stromal Tumors)
- Roche’s Nursing ACE (educational information for nurses)
- Johnson & Johnson’s Psoriasis App (calculation of PASI)
or to make the lives of patients better:
- Merck’s iChemoDiary (record of treatments and medications)
- Bayer’s Kid-K (gaming for kids with hemophilia)
- Sanofi-aventis’ GoMeals (nutrition for diabetic population)
When done right, these apps can build a positive association between a brand and a lifestyle and can be integrated into every part of patients’ lives.
Pharma Goes Mobile: Making The Most Of The App Opportunity. Medical News Today, Online, on 24th of March 2011.